Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression (vol 104, pg 1202, 2019)
Citations
Altmetric
Author
Seymour, JF; Marcus, R; Davies, A; Gallop-Evans, E; Grigg, A; Haynes, A; Herold, M; Illmer, T; Nilsson-Ehle, H; Soekler, M; ...Date
2020-05-01Source Title
Haematologica: the hematology journalPublisher
FERRATA STORTI FOUNDATIONAffiliation
Medicine and RadiologyMetadata
Show full item recordDocument Type
Journal ArticleCitations
Seymour, J. F., Marcus, R., Davies, A., Gallop-Evans, E., Grigg, A., Haynes, A., Herold, M., Illmer, T., Nilsson-Ehle, H., Soekler, M., Duenzinger, U., Nielsen, T., Launonen, A. & Hiddemann, W. (2020). Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression (vol 104, pg 1202, 2019). HAEMATOLOGICA, 105 (5), pp.1465-1465. https://doi.org/10.3324/haematol.2020.246991.Access Status
Access this item via the Open Access locationOpen Access URL
http://doi.org/10.3324/HAEMATOL.2020.246991Export Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References